Drug
Cryptivax 1001
Cryptivax 1001: highest development phase Phase 1, developed by Epitopea Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Epitopea Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| CryptiVax-1001 NCT07665515 | Phase 1 | Ovarian Cancer |
Latest
No recent events.
Follow Cryptivax 1001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.